Core Viewpoint - Longevity science is becoming a key focus for high-end beauty brands, with Estee Lauder leading the way in its industrialization and practical application, aiming to define the future rules of the longevity science industry [3][4][21]. Group 1: Industry Trends - The concept of longevity science is complex and multidisciplinary, with few successful industrialization cases in the industry [4]. - Estee Lauder has established itself as a pioneer in the field, launching the "Skin Rejuvenation Center" in major luxury markets in China, such as Beijing and Nanjing [4][12]. Group 2: Service Model - The "Skin Rejuvenation Center" offers a one-stop anti-aging service system, combining AI skin detection, advanced spa treatments, and personalized skin age reports, making longevity science accessible to consumers [6][9]. - The center's service model differs from traditional beauty services by focusing on root causes of skin aging through precise biological markers, transitioning from symptomatic to root cause treatment [9][12]. Group 3: Technological Integration - The integration of cutting-edge anti-aging technologies, such as light therapy and oxygen therapy, represents a systematic upgrade of beauty service frameworks, marking a significant milestone in the industrialization of longevity science [12][19]. - Estee Lauder's innovative ingredient technology, such as the color peptide technology, activates longevity genes and addresses multiple aspects of skin rejuvenation [16][18]. Group 4: Research and Development - Estee Lauder has established partnerships with top academic institutions, including Stanford University, to support foundational research in longevity science [22][23]. - The company has published over 20 research papers and holds 23 patents related to color peptide technology, demonstrating its commitment to advancing the field [25][26]. Group 5: Market Positioning - The launch of the "Skin Rejuvenation Center" allows consumers to experience the benefits of longevity science firsthand, bridging the gap between theoretical research and practical application [29]. - Estee Lauder's proactive approach in the longevity science sector is attracting other brands to participate, thereby validating the future potential of the beauty industry [29].

中基长寿科学(00767)发布公告，于2025年9月13日，本公司的间接非全资附属公司中骊(海南)生命科学 技术有限公司(中骊海南)与海南博鳌超级医院有限公司(海南博鳌)签署合作协议(合作协议)，中骊海南与 海南博鳌双方共同建立"国际肿瘤精准医学中心"(医学中心)，海南博鳌负责提供中心的场地及提 供"1+X"平台的服务功能，包括但不限于：门诊、住院、检查、治疗、手术等，中骊海南负责中心的营 运并提供专家及专科技术和专科设备支援，双方共同为患者开展诊疗活动及各种科研项目。 董事会认为健康长寿科学市场的前景广阔，因为观察到全球的富裕客户更愿意接受及花费在长寿科学应 用上，以提升彼等的整体健康及免疫状况，并促进彼等身体年轻化。 签署合作协议符合本集团的长寿科学业务发展策略及计划，将有利于本集团未来的业务发展，为本集团 进一步拓展国内市场奠定了坚实的基础。董事会相信签署合作协议进一步完善本集团在长寿科学诊断及 医疗服务领域的布局，为本集团开拓新的长寿科学收入来源，以期长远为本集团带来更加稳定及持续增 长的收入。 ...

签署合作协议符合本集团的长寿科学业务发展策略及计划，将有利于本集团未来的业务发展，为本集团 进一步拓展国内市场奠定了坚实的基础。董事会相信签署合作协议进一步完善本集团在长寿科学诊断及 医疗服务领域的布局，为本集团开拓新的长寿科学收入来源，以期长远为本集团带来更加稳定及持续增 长的收入。 董事会认为健康长寿科学市场的前景广阔，因为观察到全球的富裕客户更愿意接受及花费在长寿科学应 用上，以提升彼等的整体健康及免疫状况，并促进彼等身体年轻化。 智通财经APP讯，中基长寿科学(00767)发布公告，于2025年9月13日，本公司的间接非全资附属公司中 骊(海南)生命科学技术有限公司(中骊海南)与海南博鳌超级医院有限公司(海南博鳌)签署合作协议(合作 协议)，中骊海南与海南博鳌双方共同建立"国际肿瘤精准医学中心"(医学中心)，海南博鳌负责提供中心 的场地及提供"1+X"平台的服务功能，包括但不限于：门诊、住院、检查、治疗、手术等，中骊海南负 责中心的营运并提供专家及专科技术和专科设备支援，双方共同为患者开展诊疗活动及各种科研项目。 ...

Group 1 - The company, Zhongji Changshou Science (00767.HK), has signed a cooperation agreement with Hainan Boao Super Hospital to establish an "International Precision Medicine Center for Oncology" [1] - Hainan Boao will provide the center's facilities and services, while Zhongji Changshou will manage operations and provide expert support and specialized equipment [1] - The Boao Super Hospital is recognized as a pioneer in China's medical field, leveraging special policies to utilize advanced foreign medical technologies and services [1] Group 2 - The board believes that the market for longevity science is promising, as affluent clients are increasingly willing to invest in longevity applications to enhance their health and vitality [2] - The cooperation agreement aligns with the company's strategy for developing longevity science, laying a solid foundation for future business expansion in the domestic market [2] - The agreement is expected to enhance the company's positioning in the longevity science diagnostic and medical service sectors, creating new revenue streams for stable and sustainable growth [2]

Core Viewpoint - The article discusses the emergence of a "Longevity Era" driven by advancements in life sciences and AI, highlighting L'Oréal's innovative project "The Beauty of Longevity" aimed at redefining beauty standards in the context of longevity [3][5][11]. Group 1: Project Overview - L'Oréal's "The Beauty of Longevity" project encompasses three dimensions: scientific health, cognitive reshaping, and cultural economy, aiming to revolutionize traditional longevity concepts [5][11]. - The project is metaphorically described as a "tree of life," where scientific health serves as the roots, cultural concepts as the branches, and social economy as the leaves, symbolizing a new understanding of beauty and age [5][11]. Group 2: Scientific Approach - L'Oréal's integration of longevity science into skincare has garnered significant attention, marking a pivotal shift in the beauty industry towards a longevity-driven paradigm [7][19]. - The company has published 43 research papers on longevity science over the past 15 years, indicating a strong commitment to this field [14][35]. Group 3: Market Trends and Demographics - The average human lifespan has increased by 30 years over the past century, with projections indicating that by 2040, 20% of the global population will be over 60 years old [11]. - The demand for healthy and fulfilling lives is driving the growth of the longevity industry, with skin health being a critical factor for quality longevity [11][12]. Group 4: Technological Innovations - L'Oréal has developed an AI-driven diagnostic tool, the Lancôme "Cell Bioprint," which analyzes skin biomarkers to provide personalized anti-aging solutions [26][27]. - The company has created a "Longevity AI Cloud" that maps over 267 skin longevity biomarkers, revealing complex mechanisms affecting skin vitality [25][26]. Group 5: Strategic Collaborations - L'Oréal collaborates with various biotech companies to innovate active ingredients and enhance product offerings, such as the partnership with Swiss biotech company Timeline [30][31]. - The company emphasizes the importance of integrating with China's vibrant tech ecosystem to accelerate the commercialization of longevity science [34][41]. Group 6: Cultural Resonance - The "New Age Beauty" concept aligns with traditional Chinese wellness philosophies, emphasizing a holistic approach to health and beauty [45][46]. - The naming of the project reflects a deep understanding of Chinese culture, focusing on biological age and lifelong beauty rather than just superficial aesthetics [46][47]. Group 7: Future Implications - L'Oréal's strategic focus on longevity science is expected to set a new standard in the beauty industry, promoting a model that prioritizes scientific-driven and proactive health solutions [41][42]. - The company's efforts in this domain are not only commercially driven but also aim to enhance the quality of life, merging beauty with overall life quality [47].

Core Viewpoint - Zhongji Changshou Science (00767) has entered into a memorandum of cooperation with Haoshiduo (Shenzhen) Biotechnology Co., Ltd. to collaborate on longevity detection and management services, aiming to provide longevity-related products and health consultation services in the health industry [1][2] Group 1 - The cooperation will involve Zhongji Changshou's subsidiary, Hongfeng Development, providing product services and management system support, while Haoshiduo will supply domestic customer resources and market sales channels [1] - Haoshiduo is an innovative biotechnology company engaged in health, biotechnology research and development, and artificial intelligence application software development, with strong customer base and market expansion capabilities [1] - The board believes that the health and longevity science market has broad prospects, as wealthy customers globally are increasingly willing to invest in longevity science applications to enhance their overall health and immune status [1] Group 2 - The memorandum aligns with the group's strategy for developing longevity science business and is expected to benefit future business growth [2] - The board is confident that the cooperation will enhance the group's layout in the longevity science diagnostics and medical services sector, opening new revenue sources in longevity science [2] - The aim is to achieve more stable and sustainable revenue growth for the group in the long term [2]

Core Viewpoint - Zhongji Longevity Science (00767) has signed a memorandum of cooperation with Haoshiduo (Shenzhen) Biotechnology Co., Ltd. to collaborate on longevity detection and management services, aiming to provide longevity-related health products and services [1][2] Group 1: Cooperation Details - The cooperation involves Zhongji's subsidiary, Hongfeng Development, providing product services and management system support, while Haoshiduo will supply domestic customer resources and market sales channels [1] - Haoshiduo is an innovative biotechnology company engaged in health, biotechnology research and development, and AI application software development, with strong market capabilities and brand promotion [1] Group 2: Market Outlook - The board believes the health longevity science market has significant potential, as affluent customers are increasingly willing to invest in longevity applications to enhance their overall health and immune status [1] - The memorandum aligns with the group's longevity science business development strategy, which is expected to enhance the company's positioning in the longevity science diagnostics and medical services sector, creating new revenue streams for stable and sustainable growth [2]

Group 1 - The company, Zhongji Changshou Science, has signed a memorandum of cooperation with Haoshiduo Biotechnology to collaborate on longevity detection and management services [1] - The partnership aims to provide longevity biological products, medical testing, health consulting services, and management solutions within the health industry [1] - The company operates through its subsidiary, Hongfeng Development, which focuses on longevity science research, medical testing, biological products, and management [1] Group 2 - The board believes that the health and longevity science market has significant potential, as affluent customers are increasingly willing to invest in longevity applications to enhance their overall health and immune systems [2] - The memorandum aligns with the company's strategic development plan in the longevity science sector, which is expected to benefit future business growth [2] - The collaboration is anticipated to enhance the company's positioning in the longevity science diagnostics and medical services field, creating new revenue streams for long-term stable growth [2]

Group 1 - The company, Zhongji Changshou Science, announced a joint venture agreement with Huali (Guangdong) Life Science Technology Co., Ltd. to establish a joint venture in China, with Zhongji Health holding 51% and Huali Life holding 49% of the equity [1] - The initial registered capital of the joint venture is set at RMB 1 million, which will be contributed by both parties according to their respective equity ratios [1] - The joint venture aims to provide longevity health services in China, capitalizing on the growing demand from affluent customers willing to invest in longevity science applications to enhance their overall health and immune status [1] Group 2 - The establishment of the joint venture aligns with the company's strategic development plan in the longevity science sector and is expected to benefit future business growth [2] - The joint venture will create a leading life science industry empowerment platform, integrating academic conferences, technology transfer, and industrial implementation into a cohesive ecosystem [2] - The board believes that the joint venture will enhance the company's positioning in the longevity science diagnostics and medical services field, opening new revenue sources for long-term stable and sustainable growth [2]